Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biochemical Pharmacology

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bcp.2011.01.011PMID 21295012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymorphisms of decoy receptor 3 are associated with risk of esophageal squamous cell carcinoma in Chinese Han

  2010cited by this paper
• Decoy receptor 3 protects non-obese diabetic mice from autoimmune diabetes by regulating dendritic cell maturation and function.

  2010cited by this paper
• Changes in the expression of decoy receptor 3 in granulosa cells during follicular atresia in porcine ovaries.

  2010cited by this paper
• The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of soluble decoy receptor 3

  2010cited by this paper
• Immunology: TL1A in the inflammatory network in autoimmune diseases

  2010influential reference
• High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis.

  2010influential reference
• Serum decoy receptor 3 level: A predictive marker for nodal metastasis and survival among oral cavity cancer patients

  2010influential reference
• High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers

  2009cited by this paper
• The many roles of FAS receptor signaling in the immune system.

  2009cited by this paper
• DcR3 protects THP-1 macrophages from apoptosis by increasing integrin alpha4.

  2009cited by this paper
• Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells.

  2009cited by this paper
• The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.

  2009cited by this paper
• Decoy receptor 3 expression during the menstrual cycle and pregnancy, and regulation by sex steroids in endometrial cells in vitro.

  2009cited by this paper
• Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.

  2009cited by this paper
• Therapeutic Potential of VEGI/TL1A in Autoimmunity and Cancer.

  2009influential reference
• Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome.

  2009cited by this paper
• Significance of increased expression of decoy receptor 3 in chronic liver disease.

  2009cited by this paper
• Targeting the LIGHT-HVEM pathway.

  2009influential reference
• DcR3 Protects Islet β Cells from Apoptosis through Modulating Adcyap1 and Bank1 Expression1

  2009cited by this paper
• Role of TL1A in the Pathogenesis of Rheumatoid Arthritis1

  2009cited by this paper
• Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease

  2008influential reference
• Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome

  2008cited by this paper
• Expression of decoy receptor 3 in liver tissue microarrays.

  2008influential reference
• Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.

  2008cited by this paper
• Isolation of epidermal cells and cDNA cloning of TNF decoy receptor 3 of conger eel, Conger myriaster.

  2008cited by this paper
• Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus

  2008cited by this paper
• The Death Receptor 3–TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis

  2008influential reference
• Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3).

  2008cited by this paper
• Functional characterisation of decoy receptor 3 in Crohn’s disease

  2008cited by this paper
• Decoy Receptor 3 Expression in AsPC-1 Human Pancreatic Adenocarcinoma Cells via the Phosphatidylinositol 3-Kinase-, Akt-, and NF-κB-Dependent Pathway1

  2008influential reference
• Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis.

  2008cited by this paper
• Molecular cloning and preliminary expression analysis of banded dogfish (Triakis scyllia) TNF decoy receptor 3 (TNFRSF6B).

  2008cited by this paper
• Decoy receptor 3 is a prognostic factor in renal cell cancer.

  2008influential reference
• LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor.

  2008influential reference
• Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3.

  2008cited by this paper
• Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways

  2008cited by this paper
• Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.

  2008cited by this paper
• Lymphotoxin beta receptor-dependent control of lipid homeostasis.

  2007cited by this paper
• Differential cellular expression of LIGHT and its receptors in early gestation human placentas.

  2007influential reference
• Attenuation of Bone Mass and Increase of Osteoclast Formation in Decoy Receptor 3 Transgenic Mice*

  2007cited by this paper
• Epstein-Barr Virus Transcription Activator Rta Upregulates Decoy Receptor 3 Expression by Binding to Its Promoter

  2007cited by this paper
• Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice.

  2007cited by this paper
• Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.

  2007cited by this paper
• Lymphotoxin ß Receptor–Dependent Control of Lipid Homeostasis

  2007cited by this paper
• The Role of Death Receptor Ligands in Shaping Tumor Microenvironment

  2007cited by this paper
• The role of lymphotoxin receptor signaling in diseases.

  2007cited by this paper
• Apoptosis resistance in ulcerative colitis: High expression of decoy receptors by lamina propria T cells

  2006cited by this paper
• The Glycosaminoglycan-Binding Domain of Decoy Receptor 3 Is Essential for Induction of Monocyte Adhesion1

  2006cited by this paper
• Significant Inhibition of Human CD8+ Cytotoxic T Lymphocyte-Mediated Xenocytotoxicity by Overexpression of the Human Decoy Fas Antigen

  2006cited by this paper
• Fas activation of a proinflammatory program in rheumatoid synoviocytes and its regulation by FLIP and caspase 8 signaling.

  2006cited by this paper
• Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.

  2006cited by this paper
• LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.

  2006cited by this paper
• Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia.

  2005influential reference
• Contribution of the lymphotoxin beta receptor to liver regeneration.

  2005cited by this paper
• Overexpression of decoy receptor 3 in precancerous lesions and adenocarcinoma of the esophagus.

  2005influential reference
• Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.

  2005cited by this paper
• Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma

  2005cited by this paper
• Decoy Receptor 3 Increases Monocyte Adhesion to Endothelial Cells via NF-κB-Dependent Up-Regulation of Intercellular Adhesion Molecule-1, VCAM-1, and IL-8 Expression1

  2005cited by this paper
• Tumor necrosis factor family members and inflammatory bowel disease

  2005influential reference
• Attenuation of Th1 Response in Decoy Receptor 3 Transgenic Mice1

  2005cited by this paper
• Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease.

  2005cited by this paper
• Contribution of the Lymphotoxin β Receptor to Liver Regeneration1

  2005cited by this paper
• Transgenic Expression of Decoy Receptor 3 Protects Islets from Spontaneous and Chemical-induced Autoimmune Destruction in Nonobese Diabetic Mice

  2004cited by this paper
• Sensitization of cells to TRAIL-induced apoptosis by decoy receptor 3.

  2004cited by this paper
• Modulation of macrophage differentiation and activation by decoy receptor 3

  2004cited by this paper
• Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells

  2004cited by this paper
• Soluble Decoy Receptor 3 Induces Angiogenesis by Neutralization of TL1A, a Cytokine Belonging to Tumor Necrosis Factor Superfamily and Exhibiting Angiostatic Action

  2004cited by this paper
• Soluble decoy receptor 3: increased levels in atopic patients.

  2004cited by this paper
• Selective Induction of Tumor Necrosis Receptor Factor 6/Decoy Receptor 3 Release by Bacterial Antigens in Human Monocytes and Myeloid Dendritic Cells

  2004cited by this paper
• Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3.

  2004cited by this paper
• Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow‐derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication

  2004cited by this paper
• Quantification and detection of DcR3, a decoy receptor in TNFR family.

  2004cited by this paper
• Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma

  2003influential reference
• The CD95 type I/type II model.

  2003cited by this paper
• The Role of Apoptosis Signal-regulating Kinase 1 in Lymphotoxin- (cid:1) Receptor-mediated Cell Death*

  2003cited by this paper
• Characterization of chicken TNFR superfamily decoy receptors, DcR3 and osteoprotegerin.

  2003cited by this paper
• Pharmacokinetics, metabolic stability, and subcutaneous bioavailability of a genetically engineered analog of DcR3, FLINT [DcR3(R218Q)], in cynomolgus monkeys and mice.

  2003cited by this paper
• Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients

  2003cited by this paper
• The role of apoptosis signal-regulating kinase 1 in lymphotoxin-beta receptor-mediated cell death.

  2003cited by this paper
• The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas

  2002cited by this paper
• TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

  2002cited by this paper
• Modulation of Dendritic Cell Differentiation and Maturation by Decoy Receptor 31

  2002cited by this paper
• A novel secreted splice variant of vascular endothelial cell growth inhibitor

  2002cited by this paper
• DCR3 locus is a predictive marker for 5‐fluorouracil‐based adjuvant chemotherapy in colorectal cancer

  2002cited by this paper
• Cloning of a novel rainbow trout (Oncorhynchus mykiss) CC chemokine with a fractalkine-like stalk and a TNF decoy receptor using cDNA fragments containing AU-rich elements.

  2002cited by this paper
• Tumor Necrosis Factor Receptor Superfamily 14 Is Involved in Atherogenesis by Inducing Proinflammatory Cytokines and Matrix Metalloproteinases

  2001cited by this paper
• Modulation of T-cell responses to alloantigens by TR6/DcR3.

  2001cited by this paper
• Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.

  2001cited by this paper
• Ultraviolet Light (UV) Regulation of the TNF Family Decoy Receptors DcR2 and DcR3 in Human Keratinocytes

  2001cited by this paper
• Pancreatic Adenocarcinoma Cell Lines Show Variable Susceptibility to TRAIL-Mediated Cell Death

  2001cited by this paper
• In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor.

  2001cited by this paper
• Ultraviolet Light (UV) Regulation of the TNF Family Decoy Receptors DcR2 and DcR3 in Human Keratinocytes

  2001cited by this paper
• A Tumor Necrosis Factor Decoy Receptor Homologue Is Up-Regulated in the Brook Trout (Salvelinus fontinalis) Ovary at the Completion of Ovulation1

  2000cited by this paper
• Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas.

  2000cited by this paper
• Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster.

  2000cited by this paper
• Over‐expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients

  2000cited by this paper
• Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

  2000cited by this paper
• A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis*

  1999cited by this paper
• Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis.

  1999cited by this paper
• Apoptosis: Death deceiver

  1998cited by this paper

• DcR3 reprograms macrophage plasticity to promote wound healing and hair regeneration.

  2026cites this paper
• The infection biology of piscine myocarditis virus in Atlantic salmon: Can a local immune response aid eliminating the virus from the heart.

  2025cites this paper
• TNFSF14 (LIGHT) in intestinal inflammation: balancing immune activation and resolution in IBD

  2025cites this paper
• Transcriptome-wide association studies associated with Crohn’s disease: challenges and perspectives

  2024cites this paper
• TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis.

  2024cites this paper
• The role of NF-κB signaling pathway in viral hepatitis and gastroenteritis: pathogenesis and therapeutic applications

  2024cites this paper
• Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD

  2024cites this paper
• Oxymatrine inhibits the development of radioresistance in NSCLC cells by reversing EMT through the DcR3/AKT/GSK-3β pathway

  2023cites this paper
• Plasma tumour necrosis factor‐alpha‐related proteins in prognosis of heart failure with pulmonary hypertension

  2023cites this paper
• Evaluation of the role of serum DcR3 levels in the early clinical prognosis of patients with Crimean-Congo hemorrhagic fever.

  2023cites this paper
• A mathematical modeling technique to understand the role of decoy receptors in ligand-receptor interaction

  2023cites this paper
• Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis

  2022cites this paper
• Decoy receptor 3 is involved in epidermal keratinocyte commitment to terminal differentiation via EGFR and PKC activation

  2022cites this paper
• Breast Density and Estradiol Are Major Determinants for Soluble TNF-TNF-R Proteins in vivo in Human Breast Tissue

  2022cites this paper
• The role of decoy receptor 3 in inflammation and atherosclerosis in patients with chronic kidney disease and renal transplant patients.

  2022cites this paper
• The Role of Decoy Receptor DcR3 in Gastrointestinal Malignancy.

  2022cites this paper
• Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling

  2022cites this paper
• Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review

  2022cites this paper
• Immuno‐epigenomic analysis identifies attenuated interferon responses in naïve CD4 T cells of adolescents with peanut and multi‐food allergy

  2022cites this paper
• The dual role of the CD95 and CD95L signaling pathway in glioblastoma

  2022cites this paper
• A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3

  2022cites this paper
• T lymphocytes and preeclampsia: The potential role of T‐cell subsets and related MicroRNAs in the pathogenesis of preeclampsia

  2021cites this paper
• Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2

  2021cites this paper
• Integrated Analysis Identi es and Validates a Novel Signature Based on Immune Related Gene Predicting Survival in Bladder Urothelial Carcinoma

  2021cites this paper
• Differential regulation of G protein signaling in Arabidopsis through two distinct pathways that internalize AtRGS1

  2021cites this paper
• Serum decoy receptor 3 (DcR3): a promising biomarker for atopic asthma in children

  2021cites this paper
• Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer.

  2021cites this paper
• Correlation of Serum Decoy Receptor 3 and Interleukin-6 with Severity of Coronary Artery Diseases in Male Acute Myocardial Infarction Patients

  2021influential citation
• Host immune responses to enzootic and invasive pathogen lineages vary in magnitude, timing, and efficacy

  2021cites this paper
• Increased level of LIGHT/TNFSF14 is associated with survival in aneurysmal subarachnoid hemorrhage

  2021cites this paper
• The FasLane to ocular pathology—metalloproteinase cleavage of membrane‐bound FasL determines FasL function

  2021cites this paper
• TIPE Regulates DcR3 Expression and Function by Activating the PI3K/AKT Signaling Pathway in CRC

  2021cites this paper
• Triangulating Molecular Evidence to Prioritize Candidate Causal Genes at Established Atopic Dermatitis Loci

  2021cites this paper
• Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization

  2021cites this paper
• A structural perspective on the design of decoy immune modulators.

  2021cites this paper
• Type‐1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction

  2020cites this paper
• Peptide decoys: a new technology offering therapeutic opportunities for breast cancer.

  2020cites this paper
• Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling

  2020cites this paper
• A conserved aromatic moiety in the ectodomain is a key determinant for structural integrity and protein trafficking of TNFR superfamily

  2020cites this paper
• Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma

  2020cites this paper
• Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma

  2020cites this paper
• Whole Transcriptome Analysis of Chicken Bursa Reveals Candidate Gene That Enhances the Host’s Immune Response to Coccidiosis

  2020cites this paper
• Correlations Between Serum Decoy Receptor 3 and Airflow Limitation and Quality of Life in Male Patients with Stable Stage and Acute Exacerbation of COPD

  2020cites this paper
• Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease.

  2019cites this paper
• A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer

  2019cites this paper
• Circulating levels of inflammatory markers and DNA methylation, an analysis of repeated samples from a population based cohort

  2019cites this paper
• Decoy Receptor 3 Expression Is Associated With Wild-Type EGFR Status, Poor Differentiation of Tumor, and Unfavorable Patient Outcome.

  2019cites this paper
• Association between TL1A gene polymorphisms and systemic lupus erythematosus in a Chinese Han population

  2019cites this paper
• Low plasma levels of decoy receptor 3 (DcR3) in the third trimester of pregnancy with preeclampsia.

  2019cites this paper
• Expression and Clinical Significance of Decoy Receptor 3 in Acute-on-Chronic Liver Failure

  2019cites this paper
• Biased Signaling: Distinct Ligand-directed Plasma Membrane Signalosomes Using a Common RGS/G protein Core

  2019cites this paper
• Immune Alteration Caused by Fibrous and Particulate Environmental Substances

  2019cites this paper
• Role of prognostic biomarker decoy receptor 3 and immunomodulation in kidney diseases.

  2019cites this paper
• Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis

  2019cites this paper
• Gene expression profiles of TNF-like cytokine 1A (TL1A) and its receptors death receptor 3 (DR3) and decoy receptor 3 (DcR3) in multiple sclerosis.

  2019cites this paper
• When Cultures Fail: Postmortem Decoy Receptor 3 (DcR3) as a Marker of Antemortem Sepsis

  2019cites this paper
• Functional characterization of Decoy Receptor (DcR3) in EBV transformed cell lines from IBD patients of different allelic background and role in disease pathogenesis

  2019cites this paper
• Antipancreatic cancer effect of DNT cells and the underlying mechanism.

  2019cites this paper
• Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers.

  2019cites this paper
• An insight into the role of the death receptor CD95 throughout pregnancy: Guardian, facilitator, or foe

  2019cites this paper
• Lymphotoxin expression in human and murine renal allografts

  2018cites this paper
• Interleukin-22 reverses human islet dysfunction and apoptosis triggered by hyperglycemia and LIGHT.

  2018cites this paper
• ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression

  2018cites this paper
• Dcr3 induces proliferation, migration, invasion, and eMT in gastric cancer cells via the Pi3K/aKT/ gsK-3 β / β -catenin signaling pathway

  2018cites this paper
• Dcr3 induces proliferation, migration, invasion, and eMT in gastric cancer cells via the Pi3K/aKT/ gsK-3 β / β -catenin signaling pathway

  2018cites this paper
• Clinical significance of decoy receptor 3 upregulation in patients with hepatitis B and liver fibrosis.

  2018cites this paper
• DcR3 induces proliferation, migration, invasion, and EMT in gastric cancer cells via the PI3K/AKT/GSK-3β/β-catenin signaling pathway

  2018cites this paper
• Up-regulation of DcR3 in microbial toxins-stimulated HUVECs involves NF-κB signalling

  2018cites this paper
• Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1

  2018cites this paper
• Role of lymphotoxins in chronic inflammatory kidney diseases, kidney transplant rejection and urinary prion excretion

  2018cites this paper
• The influence of breastfeeding in breast-fed infants with atopic dermatitis.

  2017cites this paper
• DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis

  2017cites this paper
• Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model

  2017cites this paper
• Small Intestinal Neuroendocrine Tumors : Clinical Studies, Novel Serum Biomarkers and Sensitivity to Cytotoxic and Targeted Agents

  2017cites this paper
• DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.

  2017influential citation
• Mechanisms of the prevention and inhibition of the progression and development of non‐alcoholic steatohepatitis by genetic and pharmacological decoy receptor 3 supplementation

  2017cites this paper
• DcR3 promotes cell adhesion and enhances endometriosis development: DcR3 promotes cell adhesion and enhances endometriosis development

  2017cites this paper
• Decoy receptor 3 promotes cell adhesion and enhances endometriosis development

  2017cites this paper
• Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients.

  2017cites this paper
• Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions

  2017cites this paper
• DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin

  2017cites this paper
• LIGHT is increased in patients with coronary disease and regulates inflammatory response and lipid metabolism in oxLDL-induced THP-1 macrophages.

  2017cites this paper
• Identification and preclinical evaluation of the small molecule, NSC745887, for treating glioblastomas via suppressing DcR3-associated signaling pathways

  2017cites this paper
• Silica-Induced Immunotoxicity: Chronic and Aberrant Activation of Immune Cells

  2017cites this paper
• Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer in vitro

  2017cites this paper
• Tongxinluo modulates cytokine secretion by cardiac microvascular endothelial cells in ischemia/reperfusion injury.

  2016cites this paper
• DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC

  2016cites this paper
• The Janus Face of Death Receptor Signaling during Tumor Immunoediting

  2016cites this paper
• Biomarkers for diet in cancer prevention studies

  2016cites this paper
• LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro

  2016cites this paper
• Tolerancia a endotoxinas: una explicación a las infecciones recurrentes en la leucemia linfática crónica

  2016cites this paper
• Genetik und Epigenetik von allergischen Erkrankungen und Asthma

  2016cites this paper
• DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors

  2016cites this paper
• Eine molekulare und zellbiologische Untersuchung potentieller Brustkrebskandidaten durch 3D-Kulturen

  2016influential citation
• DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma in Northeast Chinese women

  2016cites this paper
• The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury

  2016cites this paper
• Skin disease and thyroid autoimmunity in atopic South Italian children.

  2016cites this paper
• Serum decoy receptor 3 is a diagnostic and prognostic biomarker in patients with colorectal cancer

  2016cites this paper
• Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease

  2016cites this paper
• LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells

  2016cites this paper